- Home
- AIRS vs SCPH Comparison
AIRS vs SCPH Comparison
Compare AIRS & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRS
- SCPH
- Stock Information
- Founded
- AIRS 2012
- SCPH 2013
- Country
- AIRS United States
- SCPH United States
- Employees
- AIRS N/A
- SCPH N/A
- Industry
- AIRS Medical/Nursing Services
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- AIRS Health Care
- SCPH Health Care
- Exchange
- AIRS Nasdaq
- SCPH Nasdaq
- Market Cap
- AIRS 166.3M
- SCPH 173.6M
- IPO Year
- AIRS 2021
- SCPH 2017
- Fundamental
- Price
- AIRS $6.15
- SCPH $5.26
- Analyst Decision
- AIRS Hold
- SCPH Strong Buy
- Analyst Count
- AIRS 3
- SCPH 3
- Target Price
- AIRS $3.75
- SCPH $14.00
- AVG Volume (30 Days)
- AIRS 789.2K
- SCPH 319.6K
- Earning Date
- AIRS 08-01-2025
- SCPH 08-07-2025
- Dividend Yield
- AIRS N/A
- SCPH N/A
- EPS Growth
- AIRS N/A
- SCPH N/A
- EPS
- AIRS N/A
- SCPH N/A
- Revenue
- AIRS $165,109,000.00
- SCPH $41,982,000.00
- Revenue This Year
- AIRS N/A
- SCPH $108.95
- Revenue Next Year
- AIRS $4.90
- SCPH $73.83
- P/E Ratio
- AIRS N/A
- SCPH N/A
- Revenue Growth
- AIRS N/A
- SCPH 138.10
- 52 Week Low
- AIRS $1.53
- SCPH $1.94
- 52 Week High
- AIRS $9.20
- SCPH $6.28
- Technical
- Relative Strength Index (RSI)
- AIRS 57.17
- SCPH 58.63
- Support Level
- AIRS $5.16
- SCPH $4.96
- Resistance Level
- AIRS $6.39
- SCPH $5.58
- Average True Range (ATR)
- AIRS 0.52
- SCPH 0.34
- MACD
- AIRS -0.05
- SCPH -0.04
- Stochastic Oscillator
- AIRS 61.99
- SCPH 29.22
About AIRS AirSculpt Technologies Inc.
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.